CAH Articles, Cardinal Health Inc. - From 04/11/24

Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in th...

Philips (NYSE: PHG) is leaving no stone unturned to bolster its patient monitoring solutions portfolio on the back of recent collaborations. In thi...

Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...

Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 4.65% on an annualized basis producing an average annual return of ...

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equ...

The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...

Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 3.56% on an annualized basis producing an average annual return of ...

Cardinal Health Inc (NYSE:CAH) reported second-quarter FY24 adjusted EPS of $1.82, up 38% Y/Y, beating the consensus of $1.60. Sales incr...

With the Fed decision now in the rearview mirror, sentiment appears to have taken a turn for the better on the hopes of receiving strong earnings r...

The past week’s earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that woul...